Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

A woman's pelvic pain and bleeding led to finding and successfully treating a rare benign tumor in her reproductive system.

A rare ovarian tumor caused hair loss in a post-menopausal woman, which almost completely stopped after surgery.

Hydroxychloroquine effectively reduces symptoms of frontal fibrosing alopecia, especially in the first 6 months.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Frontal Fibrosing Alopecia might be an autoimmune disease.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

The study found that imaging might miss small ovarian tumors causing high testosterone, and suggested using certain testosterone levels and treatment responses to identify these tumors.

A woman's excessive hair growth and high testosterone were caused by a rare ovarian tumor, which was successfully treated with surgery.

The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Finasteride helps hair regrowth in frontal fibrosing alopecia.

Topical estrogen helps hair growth in menopausal women with no major side effects.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Frontal fibrosing alopecia can affect men's beards and leads to permanent hair loss.